Search

everythinglearnresearchcommunity

for

Search:↓

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

Baicalin may help reduce excessive male hormone levels in PCOS.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

4-O-Methylhonokiol helps protect skin cells from growth-stopping effects of a protein by regulating growth-related pathways.

Hair RiseTM microemulsion effectively promotes hair growth and treats hair loss better than standard treatments.

Personalized treatments for hair loss are becoming more effective by using genetic information.

A woman's rare benign tumor that released both cortisol and testosterone was successfully removed, improving her health.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

A substance called Cell-free fat extract can effectively treat common hair loss by increasing hair growth and density.

The engineered yeast strain BLYAS can quickly and sensitively detect androgenic chemicals.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Muscles can make their own androgens, which may help muscle growth.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Androgens like testosterone may help treat traumatic brain injury by reducing mitochondrial stress and inflammation.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

The secretome from mesenchymal stromal cells shows promise for improving facial nerve injury treatment.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

Minoxidil and Finasteride are effective for male baldness; more research is needed for hair aging treatments.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.